Growing body of peer-reviewed publications and rigorously reviewed conference research reinforces Dario's position as trusted partner for organizations seeking to reduce cost, improve outcomes and simplify...
First in-market activation of Dario's GenAI roadmap lays clinical and technical foundation for a seamless, conversational AI experience across the entire Dario platform
Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudges on hypertension outcomes
34 new employer clients added in the past two weeks expected to contribute to H1 2026 revenue
Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual care
NEW YORK , Nov. 13, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced financial results for the...
Analysis based on claims data highlights significant cost savings, especially among high-risk members
Company to host conference call and webcast at 8:30 a.m. Eastern Time
NEW YORK , Oct. 29, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating DarioHealth Corp. (NASDAQ: DRIO) on behalf of the company's shareholders. The investigation...
New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform